Peptide nucleic acids (PNAs) complementary to the 15 bases around the fusion point of both genomic DNA and cDNA of the promyelocytic leukemia/retinoic acid receptor (Y (PMLI RARa; P/R) hybrid gene present in acute promyelocytic leukemia cells were synthesized and shown by gel retardation experiments t o specifically bind oligonucleotides corresponding to the fusion region of the P/R molecule. PNA was also able t o successfully compete with anti-P/R DNA for duplex formation with P/R DNA and t o displace the anti-P/R DNA from dsDNA. In vitro transcribed P/R RNA from two inserts of ~3 5 0 and -700 bp were tested in gel acceleration experiments with fluorescein-conjugated PNA and showed stable binding (resistant t o denaturing conditions) of PNA to the newly transcribed RNA. Control RNA or transcripts from the noncoding strand did not bind PNA. However, this
HE PROMYELOCYTIC leukemiahetinoic acid receptor a (PML/RARa; P R ) gene is present in virtually all cases of acute promyelocytic leukemia (APL) and derives from a t( 15; 17) reciprocal chromosomal translocation' in which part of the RARa gene on chromosome 17 is fused to part of the PML gene on chromosome 15,' resulting in the expression of a chimeric PMLIRARa (P/R) messenger encoding a fusion P/R protein3
Growing evidence has suggested that the product of the P/R gene is involved in both the leukemogenesis process and in the sensitivity of APL cells to retinoic acid (RA'.') although the relative contribution to transformation of the PML-and RARa-induced pathways has not yet been established. ' . ' Peptide nucleic acid (PNA)' is a DNA mimic in which the (deoxy)ribose-phosphate backbone typical of DNA and RNA is replaced by a charge-neutral, achiral pseudopeptide backbone, preserving only the bases present in the DNA molecule. PNA forms stable complexes with complementary sequences present in both dsDNA and RNA.'." In fact PNA/ DNA hybrids show an increase in Tm over corresponding DNA/DNA complexes of at least l"C/base.* Furthermore, homopyrimidine PNAs bind very efficiently and sequence specifically to homopurine sequences in double-stranded DNA by strand displacement. Finally, it has been found that PNA can efficiently inhibit both translation and transcription in vitro. Because of these properties, combined with a high biologic stability, PNA holds promise as both an antisense and an antigene drug. However, mostly model systems have been studied"." and no general rules or conclusions regarding the use of PNA for targeting biologically relevant genes or sequences are yet available.
We present here results with several PNAs directed against the fusion region or the PML part of the P/R gene and corresponding to both genomic and cDNA sequences of the BCR 1 -type fusion.3 PNA, although able t o specifically clamp polymerase chain reaction, was incapable of inhibiting in vitro translation of the PML/RARa mRNA, even when a bis-PNA was used. Therefore, a PNA was targeted against the start region of the P/R cDNA and against poly-purine regions of the gene. Specific inhibition of in vitro translation and transcription was shown, starting at concentrations as low as 100 nmol/L. When oligonucleotides presenting the same sequence were compared, PNA proved t o be approximately 40 times more active. In conclusion, in vitro inhibition of translation and transcription of the P/R gene can be obtained with PNA; however, it is still necessary t o target the ATG start region or poly-purine regions of the gene. 0 1996 by The American Society of Hematology.
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MATERIALS AND METHODS
Oligonucleotides (ODNs)
95%. PNAs were synthesized as de~cribed.'~ Fluorescein-conjugated PNA was obtained by reacting the PNA with fluorescein isothiocyanate. PNA sequences are as follows: no. 137 (complementary to the genomic P/R fusion of patient no. Plasmids BCRl (full-length P/R cDNA, type 1 in pGEM3). LAAB, and MOL (containing partial P R inserts of 738 and 326 bases, respectively) were obtained from P.G. Pelicci (Perugia, Italy). Plasmid pCF-I (containing the full-length ret/PTC-2 cDNA") was kindly supplied by I. Bongarzone (Milan, Italy / n v i f w transcription e.rprirnmts. Plasmids were first linearized by digestion with Hind111 (used for MOL and anti-LAAB) o r EcoRI (used for LAAB and anti-MOL). Template DNA was purified by phenol/chlorofor-m extraction and used for in vitro transcription at I pg/reaction (SP6iT7 transcription kit: Promega, Madison, W1) in the presence of 20 pCi of [cU-'*P]UTP for I O to 30 minutes at 37"C, as described." For gel acceleration experiments, cold UTP was used. Transcription was initiated from the SP6 (LAAB and anti-MOL) or T7 (MOL and anti-LAAB) site. PNA was incubated with purified DNA at 37°C for 30 minutes before starting transcription. Unincorporated UTP was removed with NUC-TRAP mini columns (Stratagene. La Jolla CA), and the samples were run on 4% to 5 8 polyacrylamide gel electrophoresis (PAGE). dried. and visualized by autoradiography. The intensity of different bands was compared USing the 620 CCD densitometer (Bio-Rad, Richmond, CA) and the l -D Analyst I1 data analysis software.
In rirro trunslrrfion experiments. Plasmids BCR I or pGF-1 were directly translated into polypeptides using the TNT T7-coupled reticulocyte lysate system (Promega). Briefly. 1 pg DNA, T7 RNA polymerase, TNT buffer, aminoacid mixture. L-[ "S]-methionine (20 pCi), RNasin (20 U; Promega). TNT rabbit reticulocyte lysate. and PNA were mixed and incubated at 37 "C for 30 minutes, according to TNT protocol. As internal controls, 0.5 pg of the pGF-I plasmid was incubated in the same tuhe. Samples were run in 6% to 7%. sodium dodecyl sulfate-PAGE (SDS-PAGE), dried, and visualized by autoradiography. Molecular weight markers (Bio-Rad) were run in parallel.
Polymerase chain reaction (PCR) clamping. Anti-P/R PNA no. 205 and the bis-PNA no, 496 were used to target the fusion point of P R in the BCRl plasmid. Two plasmids carrying the 8-glucocerebrosidase gene and the factor V gene were used as specificity controls.lx.l" The following primers were used for amplification: 5'-GGA GGC AGC CAT TGA GAC-3' (forward) and 5'-CAT AGT GGT AGC CTG AGG ACT T-3' (reverse) for P/R, S'-GAA TGT CCC AAG CCT TTG A-3' (forward) and 5'-AAG CTG AAG CAA GAG AAT CC-3' (reverse) for P-glucocerebrosidase, and 5'-GGA ACA ACA CCA TGA TCA GAG CA-3' (forward) and S'-TAG CCA GGA GAC CTA ACA TGT TC-3' (reverse) for factor V. The amplified fragments were, respectively, 131, 357, and 287 bp in length. PCR was performed in a 50 pL reaction containing 3 ng of the plasmid, 200 pmol/L of each dNTP, 0.5 pmollL of each primer.
huffer (50 mmol/L KCI, 1 0 mmol/L, Tris-HCI, pH 8.3), 2.6 mmol/ L MgCI:. and 1.25 U Taq polymerase on the GenAmp PCR System 9600 machine (Perkin Elmer, Branchhurg, NJ) using a 4-stcp cycle'": 88°C for 15 seconds. 62°C for l minute. 54°C for 20 seconds. 72°C for 90 seconds for 25 cycles. PNA was either preincuhated overnight with the plasmid o r added in the tube at the beginning of thc reaction.
RESULTS
Anti-P/R PNA is able to hind specijically to P/R DNA and to successfully compete with anti-P/R DNA (gel retardation experiments). To investigate the ability of PNA to bind P/ R DNA, 15 mer ODNs corresponding to the fusion region of the P/R gene were synthesized and used in gel retardation experiments.
Two types of P/R fusions were studied. Initially. the sequence corresponding to genomic fusion (from the patient identified as no. 8) was targeted. In this patient. the fusion region (AGAGTTTACGAGGGA) has an approximate A+G content of 75%. Gel retardation experiments are shown in Fig 1A . Both anti-P/R DNA and PNA can bind to P/R DNA. Anti-P/R DNA slows the migration of P/R DNA (lanes 2 and 3. consistent with the formation of dimers). PNA forms two bands (lanes 4 and 5 ) that migrate more slowly than the DNA/DNA dimers because of the lack of net charges on the PNA molecule. These two bands are compatible with the formation of a PNNDNA duplex (lower band) and of a nonperfect PNAJDNA triplex. As expected, the triplex predominates when working in an excess of PNA (lane 4). If DNADNA dimers are allowed to form and then are challenged with PNA (lane 61, then about 48% of the DNA/ DNA complex is displaced, with the formation of PNNDNA dimers (and triplexes, upper band). However, if the second incubation is performed at 37°C instead of at room temperature, then a near complete displacement of the DNADNA dimers is observed (Fig IB, lanes X through 1 I) , showing the superior binding efficiency of PNA. Anti-P/R PNA does not bind to PML or RARa ODNs (mismatch of S and 7 bases. respectively) or to anti-P/R ODN. PNA also does not interfere with the binding of PML (Fig IA, lanes 9 through  11) and RARa (data not shown) ODNs to their complementary ODNs.
Subsequently, ODNs corresponding to the BCRl type cDNA (GAGGCAGCCATTGAG) were used (Fig IC) . This represents a mixed sequence with only 66% A+G content: thus, only PNNDNA duplexes are observed (lanes S through 7). PNA successfully competed with DNA (lane 8, 77% PNA/DNA I: 23% DNA/DNA). Anti-P/R PNA is able to successfully displace anti-P/R DNA from DNADNA dimers and to bind specifically to P/R ODN when incubated with the DNA/DNA dimers for at least 60 minutes at 37°C (lanes I O through 12). These experiments show that PNA is able to specifically bind to ODN representing both the genomic and the cDNA P/R fusion region and to successfully compete with anti?/ R DNA for binding to P/R DNA.
Ability of' PNA to hind transcripts qf the P/R gemJ (gel accelercrtion experiments). P/R RNA was transcribed in vitro from the two plasmids LAAB and MOL that contain 10, and 5 pmol, respectively); lanes 8 and 9, P/R + anti-P/R ODN (10 pmol, step 1) followed by anti-P/R PNA (step 2, 37°C; 100 and 10 pmol, respectively); lanes 10 and 11, same as lanes 8 7) ; lane 8,004 + anti-P/R ODN and PNA; lanes 9 through 12, 004 + anti-P/R ODN (100 pmol, step 1) followed by PNA (100 pmol, step 2 [37"Cll for 30 minutes llane 9) or for 60, 120, or 240 minutes (lanes 10 through 12, respectively). All samples were run in 12% PAGE. The bands corresponding to ssDNA, dsDNA, PNA/DNA, and PNAJ DNA are indicated. the fusion point. Because PNA does not contain phosphate molecules, conventional binding techniques could not be used. Therefore, a fluorescein-conjugated PNA-based technique was used. PNA is not charged and therefore is expected to have little migration when electric current is applied. The binding to RNA would confer mobility to PNA, which can be visualized as a green signal by direct UV illumination of the dried gel. An example using ODNs is presented in Fig 2A. PNA no. 205 (500 ng [=l00 pmol]), which binds specifically to P R ODN, can migrate into the gel and forms a discrete band. Down to 40 pmol of PNA can be visualized (data not shown). Transcripts from the MOL and LAAB plasmids (containing partial P R inserts of 326 and 738 bases, respectively) were then incubated with PNA and run on PAGE (Fig 2B through D) . Unbound PNAs show little shift, as expected. When incubated with P R transcripts, PNA migrates (gel acceleration) at positions compatible with the length of the transcripts. Incubation of PNA with antisense transcripts or with unrelated control RNAs did not induce any shift of the PNA (Fig 2C, lanes 1 and  2) . Whereas control PNAs enter the gel in Fig 2C, they apparently fail to form a band in Fig 2B. Although a clear explanation is not available, it is possible that, in the experiment depicted in Fig 2B, a partial precipitation of PNA occurred that prevented control samples from forming a distinct band.
The binding of PNA to its target is very stable, because, once formed, it is resistant to denaturing ( I O molL urea) conditions (Fig 2D) . In conclusion, PNA is able to bind specifically P/R RNA and forms a stable complex.
PNA-mediated inhibition of PCR amplification of P/R.
To establish a possible functional role for the observed binding of PNA no. 205 (and of its corresponding bis PNA no. 496) to nucleic acids, we performed a PCR clamping test?" In this assay, the specific arrest of Taq polymerase-mediated amplification of a P/R sequence by PNA is assessed. PNA no. 205 failed to affect the amplification of a 13 l-bp fragment containing the P/R fusion point, whereas PNA no. 496 showed significant ( 2 50%) inhibition in the pmolL range. The block was significantly increased when PNA no. 496 was preincubated overnight with template DNA, reaching a significant inhibition at 300 nmol/L and a total block at 2 0, 50, 100, 300, and 500 nmolIL (lanes 1 through 5,  respectively) . was sequence-specific, because parallel amplifications of pglucocerebrosidase and factor V gene fragments were not affected (data not shown).
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In vitro translation experiments. The ability of anti-P/R PNA to inhibit the in vitro translation of the P/R fusion protein from the expression plasmid BCRl was evaluated. PNA no. 205, which showed a stable binding to the P/R fusion region, was added to the in vitro translation assay, but failed to inhibit the translation of the P/R polypeptide from plasmid BCRl (data not shown). A second PNA (no. 496), synthesized as a bis-PNA" against the fusion region, inhibited translation at high (>2 pmol/L) concentrations, but in a nonspecific way (data not shown). Similarly, both PNAs failed to inhibit the transcription of the noncoding strand of MOL and LAAB.
Because the targeting of the fusion region proved unfeasible, PNAs were directed against the PML start codon region (no. 752, residues 122-1 36) and against a poly-purine region (no. 783. residues 1490-99) of PML, which is retained in the fusion gene, to inhibit translation. Figure 3 shows the results using PNA 752 to inhibit in vitro translation of the P/R protein from plasmid BCRI. Specific inhibition starts at 50 to 100 nmol/L and complete inhibition is achieved at 300 nmol/L. Translation of the control plasmid pGF-I (lower band) was unaffected. The activity of PNA 752 was also compared with an ODN with the same sequence (Fig 4A and B) . The ODN achieved a significant translation inhibition at 8 pmol/L. The concentrations of 200 nmol/L (PNA) and 8 pmol/L (ODN) achieved similar (=80%) translation inhibition. The activity of PNA 783 was also evaluated (Fig 4C) . At 300 nmol/L, a 60% inhibition was obtained (compared with 100% for PNA 752); no accumulation of a truncated product was evident. Further increases in concentration led to nonspecific inhibition.
In vitro transcription experiments. A bis PNA (no. 753) targeted against a homopurine stretch in the PML gene was used to inhibit in vitro transcription from the LAAB plasmid (Fig 5 ) . This PNA would be expected to block transcription approximately 100 bases after the T7 promoter site. A truncated =lOO-base-Iong transcript became evident at 500 nmol/L, progressively increased in intensity at 1 and 2 pmol/ L, and reached 30% of the total transcript (as assessed by densitometric analysis). A proportional decrease of the fulllength transcript was also observed. Further increases in PNA concentration resulted in the nonspecific inhibition of both the full-length and the truncated products.
These experiments show that PNAs directed against the start codon or poly-purine regions can specifically inhibit both in vitro transcription and translation of the P/R gene. PNA can achieve a degree of translation inhibition similar to that obtained using 40 times higher concentrations of ODN. Inhibition of transcription can be achieved by targeting a poly-purine region in the coding DNA strand. When the same sequence ODN was evaluated, it appeared to be several times less effective than PNA on a molar basis. A different PNA (no. 783), directed against a homopurine region of the cDNA, also exhibited some activity at 300 nmol/L; however, this became nonspecific at higher concentrations. This observation requires further investigation. It is truncated important to note that, when specific translation inhibition mnscript was obtained with PNA no. 783, no accumulation of a truncated product was found, which is at variance with in vitro transcription (see below). This fact could be explained with the successive block of several translation complexes at dif- 
DISCUSSION
The hybrid protein P/R epitomizes one of the growing list of fusion molecules generated by chromosomal translocations associated with human cancer. The causal role of the P/R protein and of most other fusion proteins in the pathogenesis of human cancer is now well established, although the molecular mechanism by which each protein transforms cells is still obscure in many cases. Our ability to modulate the expression andor the function of fusion proteins is even more limited at present.
PNA represents a promising tool in this direction. PNA could potentially be used as both an antisense and an antigene molecule. We initially verified the DNA-binding ability of PNA using labeled ODN representing the fusion region of the P/R molecule. Subsequent experiments confirmed that anti-P/R PNA could bind to transcripts from the P/R gene.
Unfortunately, even a stable binding to the fusion region of the mRNA was not sufficient to inhibit P/R protein synthesis, although specific termination of PCR amplification of a fragment containing the P/R fusion was attained. It is possible that the ribosomes could displace the bound PNA and continue synthesis downstream. These data also show the difficulties present when trying to precisely target the fusion region of hybrid genes, mainly due to the limited variability and number of sequences that can be generated. However, this problem is not restricted to the targeting of DNA or RNA, but is also present when different strategies (eg, the elicitation of an immune response against the fusion region of the P/R are followed. Subsequently, the potential target region was extended to the entire PML part of the fusion molecule. Because it is known that non-RNase H-activating ODN analogues can have better translation inhibition when targeted to the initiation codon, a new 15-mer PNA was prepared. With this PNA, a specific and sensitive translation inhibition was obtained at concentrations as low as 100 nmol/L. This repreferent positions and the ensuing release of polypeptides of distinct molecular weight that, therefore, do not form a single band. The absence, or nonstoichiometrical amount, of a truncated translation product has been observed in other systems A bis-PNA directed against a homopurine region of the coding strand was used to evaluate transcription inhibition. In this case, a progressive accumulation of a truncated product (with decrease in the full-length transcript) was observed, although at high PNA concentrations, close to the micromoles per liter mark, and without reaching a complete suppression. In this case, higher concentrations produced nonspecific inhibition of both the full-length and truncated transcript.
Although additional important information are not yet available, including the ability of PNA to enter cells:4 these data support the possible use of PNA as a specific tool to modulate gene expression. Although results in intact cells are an essential prerequisite for clinical development, these data show that an oncogene can be targeted at both the translation and transcription level and epitomize potentials and limitations of targeting different regions of the gene. In this context, it is worth saying that, although the targeting of the PML start (ATG) region would not be absolutely tumor-specific, the function of PML in normal cells could be easily vicariated, as data in PML knock-out mice seem to suggest (P.P. Pandolfi, unpublished observations).
The observed inhibition of transcription, although not complete, is particularly promising, because it is known that only few molecules (2 in theory) need to be blocked inside a cell to completely inhibit transcription. PNA could thus be used as an antigene molecule, with the aim of selectively blocking gene transcription.
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